INTEGRATED BIOPHARMA Business Summary

Integrated BioPharma Inc. (INBP) operates as a diversified nutraceutical company generating revenue primarily through the contract manufacturing, distribution, and marketing of vitamins, nutritional supplements, and herbal products. The company’s operations are bifurcated into two primary segments: Contract Manufacturing, managed by its subsidiary Manhattan Drug Company (MDC), and Other Business Lines, which encompasses warehousing, fulfillment services, and the distribution of raw materials and branded products such as Peaceful Sleep and Wheatgrass. Revenue is heavily driven by a high-concentration model, with two major customers—Life Extension and Herbalife—accounting for approximately 89% of consolidated net sales as of early 2026. Within the competitive landscape, INBP competes directly with contract manufacturers and nutraceutical firms such as Natural Alternatives International (NAII), Zivo Bioscience Inc. (ZIVO), and Usana Health Sciences (USNA), positioning itself as a specialized small-cap player focused on high-volume production for established health and wellness brands. The company was founded in 1980 by the late E. Gerald Kay, a prominent figure in the nutritional industry who previously served as a mentor and early investor to the founders of Rexall Sundown. Current leadership is held by Co-Chief Executive Officers Christina Kay and Riva Sheppard, both of whom have been with the company since the early 1990s and assumed their roles in 2019 to maintain the founding family's legacy. The executive team is supported by Dina L. Masi, who serves as Chief Financial Officer and Senior Vice President with an extensive background in financial consulting and SEC reporting. The Board of Directors includes notable industry veterans such as Damon DeSantis, a board member of Celsius Holdings (CELH) and son of the late Carl DeSantis, and William H. Milmoe, Co-Chairman of Celsius Holdings, providing the company with significant pedigree and strategic connections within the global health and beverage sectors.